Surgenex® is an industry leading contract research and manufacturing organization specializing in human cellular and tissue-based products. Surgenex® has assembled a team of dedicated professionals committed to delivering products that meet stringent quality and safety standards. We offer a full suite of processing capabilities to supply traditional allografts through customized, innovative therapies. Our in-house development team focuses on exceeding expectations by combining in-depth industry experience and a robust quality system to deliver exceptional quality, best in class customer service, and a commitment to on time delivery. Current Capabilities Include: Full Suite of Birth Tissue Allografts Customized Demineralized Bone Matrix Implants Allografts Solutions Supporting Implant and Reconstructive Dentistry Advanced Allograft Therapies Acellular Dermal Matrix Precision Milled Structural Allografts to Support Spinal Surgery
Looking for a particular Surgenex employee's phone or email?
The Surgenex annual revenue was $5.7 million in 2026.
Jw Freiermuth is the Vice President, Market Development- Surgical of Surgenex.
112 people are employed at Surgenex.
Surgenex is based in Scottsdale, Arizona.
The NAICS codes for Surgenex are [81, 812, 81299, 8129].
The SIC codes for Surgenex are [72, 729].